{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:52Z","timestamp":1759451932750,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.06.052","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T02:50:43Z","timestamp":1656039043000},"page":"4296-4300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity"],"prefix":"10.1016","volume":"40","author":[{"given":"Murat","family":"Seyran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.052_b0005","doi-asserted-by":"crossref","unstructured":"Adam KM. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2). Trop Dis Travel Med Vaccines 2021;7.10.1186\/s40794-021-00147-1.","DOI":"10.1186\/s40794-021-00147-1"},{"key":"10.1016\/j.vaccine.2022.06.052_b0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0015","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.4049\/jimmunol.178.11.6912","article-title":"Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway","volume":"178","author":"Agrawal","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0025","doi-asserted-by":"crossref","first-page":"772240","DOI":"10.3389\/fimmu.2021.772240","article-title":"Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents","volume":"12","author":"Bo\u0161njak","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0030","doi-asserted-by":"crossref","first-page":"103104","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID- 19 pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2022.06.052_b0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with Coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009337","article-title":"Wound repair and regeneration: Mechanisms, signaling, and translation","volume":"6","author":"Eming","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2022.06.052_b0045","doi-asserted-by":"crossref","first-page":"e12548","DOI":"10.7717\/peerj.12548","article-title":"EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes","volume":"9","author":"Ferreira","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2022.06.052_b0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","article-title":"Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein","volume":"53","author":"Ferretti","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2022.06.052_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22811-y","article-title":"Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features","volume":"12","author":"Gangaev","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.06.052_b0060","doi-asserted-by":"crossref","unstructured":"Grau-Exp\u00f3sito J, S\u00e1nchez-Gaona N, Massana N, Suppi M, Astorga-Gamaza A, Perea D, et al. Peripheral and lung resident memory T cell responses against SARS-CoV-2. Nat Commun 2021;12. 10.1038\/s41467-021-23333-3.","DOI":"10.1038\/s41467-021-23333-3"},{"key":"10.1016\/j.vaccine.2022.06.052_b0065","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 Coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0070","doi-asserted-by":"crossref","unstructured":"Gupta AK, Khan MS, Choudhury S, Mukhopadhyay A, Sakshi, Rastogi A, et al. CoronaVR: A computational resource and analysis of epitopes and therapeutics for severe acute respiratory syndrome Coronavirus-2. Front Microbiol 2020;11.10.3389\/fmicb.2020.01858.","DOI":"10.3389\/fmicb.2020.01858"},{"key":"10.1016\/j.vaccine.2022.06.052_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nri2236","article-title":"Regulation of immunological homeostasis in the respiratory tract","volume":"8","author":"Holt","year":"2008","journal-title":"Nat Rev Immunol"},{"year":"2001","series-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway","key":"10.1016\/j.vaccine.2022.06.052_b0085"},{"key":"10.1016\/j.vaccine.2022.06.052_b0090","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.vaccine.2021.03.077","article-title":"The development of COVID-19 vaccines in the United States: Why and how so fast?","volume":"39","author":"Kuter","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.052_b0095","doi-asserted-by":"crossref","first-page":"732913","DOI":"10.3389\/fimmu.2021.732913","article-title":"Immunometabolic dysregulation at the intersection of obesity and COVID-19","volume":"12","author":"Khwatenge","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0100","doi-asserted-by":"crossref","first-page":"27063-4","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.06.052_b0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.06.052_b0110","article-title":"Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2022.06.052_b0115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.06.052_b0120","doi-asserted-by":"crossref","first-page":"103743","DOI":"10.1016\/j.isci.2022.103743","article-title":"Immunity to SARS-CoV-2 up to 15 months after infection","volume":"25","author":"Marcotte","year":"2022","journal-title":"IScience"},{"key":"10.1016\/j.vaccine.2022.06.052_b0125","doi-asserted-by":"crossref","first-page":"22375","DOI":"10.1038\/s41598-020-78758-5","article-title":"Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs","volume":"10","author":"Malone","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.06.052_b0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.06.052_b0135","doi-asserted-by":"crossref","first-page":"109414","DOI":"10.1016\/j.celrep.2021.109414","article-title":"Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19","volume":"36","author":"Neidleman","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2022.06.052_b0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0145","doi-asserted-by":"crossref","first-page":"2001727","DOI":"10.1183\/13993003.01727-2020","volume":"56","author":"Ong","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2022.06.052_b0150","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 Coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0155","article-title":"Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs","volume":"118","author":"Pan","year":"2021","journal-title":"Proc NatlAcad Sci U S A"},{"key":"10.1016\/j.vaccine.2022.06.052_b0160","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memoryCD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41590-021-01095-w","article-title":"Prolonged activation of nasal immune cell populations and development of tissue resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19","volume":"23","author":"Roukens","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41514-021-00060-z","article-title":"Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis","volume":"7","author":"R\u00fcbe","year":"2021","journal-title":"NPJ Aging Mech Dis"},{"key":"10.1016\/j.vaccine.2022.06.052_b0180","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.052_b0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.06.052_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf7550","article-title":"SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients","volume":"6","author":"Saini","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0195","article-title":"High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19. JCI","volume":"5","author":"Schub","year":"2020","journal-title":"Insight"},{"key":"10.1016\/j.vaccine.2022.06.052_b0200","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0210","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2022.06.052_b0215","article-title":"The structural basis of accelerated host cell entry by SARS-CoV-2","author":"Seyran","year":"2020","journal-title":"FEBS J"},{"issue":"797","key":"10.1016\/j.vaccine.2022.06.052_b0220","first-page":"814.e6","article-title":"Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19","volume":"54","author":"Szabo","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2022.06.052_b0225","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2022.06.052_b0230","article-title":"Robust T cell response towards spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients","volume":"100092","author":"Thieme","year":"2020","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.vaccine.2022.06.052_b0235","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1111\/febs.16105","article-title":"The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes","volume":"288","author":"Tong","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2022.06.052_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.692937","article-title":"Revelation of potent epitopes present in unannotated ORF antigens of SARS-CoV-2 for Epitope-based polyvalent vaccine design using immunoinformatics approach","volume":"12","author":"Uttamrao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.06.052_b0245","series-title":"NHC Key Laboratory of Biosafety","first-page":"83","volume":"4","author":"Zhang","year":"2022"},{"key":"10.1016\/j.vaccine.2022.06.052_b0250","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:44Z","timestamp":1759403624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":48,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22008210"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}